📊 NXTS Key Takeaways
Is Nexentis Technologies Inc. (NXTS) a Good Investment?
Nexentis Technologies exhibits critical operational failure with zero revenue in the latest period (-100% YoY) and substantial operating losses of $8.2M against only $49K gross profit, indicating either failed commercialization or a development-stage program with no market traction. Negative operating cash flow of -$1.4M with a cash runway of approximately 3 years at current burn rates, combined with minimal insider confidence signals, presents existential risk to equity holders.
Nexentis remains pre-revenue with ongoing operating losses and negative operating cash flow, offering no clear line-of-sight to profitability. Liquidity is solid and leverage minimal, but the $3.83M cash balance supports roughly a one-year runway at current burn, implying likely dilution without near-term commercialization. On fundamentals alone, risk outweighs potential until revenue traction materializes.
Nexentis Technologies Inc. Key Strengths (NXTS)
- Maintains positive stockholders equity of $13.0M despite losses
- Strong liquidity ratios (4.73x current ratio) provide short-term runway
- Minimal debt burden with only $8.4K long-term debt
- Strong liquidity (4.19x current ratio) and low liabilities
- Near-zero leverage reduces financing risk
- Low capex intensity and modest YoY loss improvement
NXTS Stock Risks: Nexentis Technologies Inc. Investment Risks
- Complete revenue collapse to zero with no apparent commercialization success
- Unsustainable cash burn of -$1.5M annually in free cash flow
- Operating losses of $8.2M indicate fundamental business model dysfunction or failed development program
- Limited time horizon before cash depletion requires dilutive financing or asset sales
- Minimal insider trading activity suggests lack of management conviction
- Pre-revenue status with a 100% YoY revenue decline
- High cash burn vs. cash on hand; dilution risk
- Unclear path to profitability and execution/regulatory hurdles
Key Metrics to Watch
- Revenue generation and return to positive sales
- Path to operating profitability and reduced cash burn rate
- Cash balance trends and runway to potential financing events
- Quarterly operating cash flow (burn rate)
- Revenue initiation and growth
Nexentis Technologies Inc. (NXTS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 4.73x current ratio provides a solid financial cushion.
NXTS Profit Margin, ROE & Profitability Analysis
NXTS vs Healthcare Sector: How Nexentis Technologies Inc. Compares
How Nexentis Technologies Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Nexentis Technologies Inc. Stock Overvalued? NXTS Valuation Analysis 2026
Based on fundamental analysis, Nexentis Technologies Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Nexentis Technologies Inc. Balance Sheet: NXTS Debt, Cash & Liquidity
NXTS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Nexentis Technologies Inc.'s revenue has grown significantly by 13% over the 5-year period, indicating strong business expansion. The most recent EPS of $-27.74 indicates the company is currently unprofitable.
NXTS Revenue Growth, EPS Growth & YoY Performance
NXTS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $2.0K | $429.0K | $0.97 |
| Q2 2025 | $17.0K | -$787.0K | $-0.18 |
| Q1 2025 | $44.0K | -$769.0K | $-0.26 |
| Q3 2024 | $9.1K | -$2.3M | $-0.39 |
| Q2 2024 | $16.5K | -$709.5K | $-0.23 |
| Q1 2024 | $43.8K | -$769.6K | $-0.26 |
| Q3 2023 | $51.2K | -$1.8M | $-1.78 |
| Q2 2023 | $31.1K | -$709.5K | $-0.10 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Nexentis Technologies Inc. Dividends, Buybacks & Capital Allocation
NXTS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Nexentis Technologies Inc. (CIK: 0001789192)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NXTS
What is the AI rating for NXTS?
Nexentis Technologies Inc. (NXTS) has a Combined AI Grade of C from Claude (D) and ChatGPT (C) with 82% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are NXTS's key strengths?
Claude: Maintains positive stockholders equity of $13.0M despite losses. Strong liquidity ratios (4.73x current ratio) provide short-term runway. ChatGPT: Strong liquidity (4.19x current ratio) and low liabilities. Near-zero leverage reduces financing risk.
What are the risks of investing in NXTS?
Claude: Complete revenue collapse to zero with no apparent commercialization success. Unsustainable cash burn of -$1.5M annually in free cash flow. ChatGPT: Pre-revenue status with a 100% YoY revenue decline. High cash burn vs. cash on hand; dilution risk.
What is NXTS's revenue and growth?
Nexentis Technologies Inc. reported revenue of $0.0.
Does NXTS pay dividends?
Nexentis Technologies Inc. does not currently pay dividends.
Where can I find NXTS SEC filings?
Official SEC filings for Nexentis Technologies Inc. (CIK: 0001789192) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NXTS's EPS?
Nexentis Technologies Inc. has a diluted EPS of $-10.74.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is NXTS's fundamental grade?
Based on our AI fundamental analysis in May 2026, Nexentis Technologies Inc. has a C grade with 82% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is NXTS stock overvalued or undervalued?
Valuation metrics for NXTS: ROE of -50.7% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is NXTS's AI grade for 2026?
Our dual AI analysis gives Nexentis Technologies Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NXTS's free cash flow?
Nexentis Technologies Inc.'s operating cash flow is $-1.4M, with capital expenditures of $71.0K.
How does NXTS compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE -50.7% (avg: 15%), current ratio 4.73 (avg: 2).